Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD5024 1% cream in papulopustular rosacea
2010-018319-13Phase 2Completed
- Sponsor
- Galderma
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in papulopustular rosacea comparing CD5024 (ivermectin) 1% cream with Vehicle cream (2 arms). Primary endpoint: Safety assessment. Started Jun 2010; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2010-018319-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018319-13.